Skip to main content
. 2021 Dec 1;1(3):e48. doi: 10.52225/narra.v1i3.48

Figure 3. Forest plot of symptoms in COVID-19 survivors. (A) Estimated prevalence of prolonged headache in COVID-19 survivor (event rate: 8.9%, 95%CI: 3.2%–22.6%, p<0.001, p Egger 1.429, p heterogeneity <0.0001. (B) Estimated prevalence of prolonged joint pain in COVID-19 survivor (event rate: 15.4%, 95%CI: 8.2%–27.2%, p<0.001, p Egger 0.692, p heterogeneity <0.0001. (C) Estimated prevalence of prolonged myalgia in COVID-19 survivor (event rate: 5.6%, 95%CI: 2.1%–14.2%, p<0.001, p Egger 1.270, p heterogeneity <0.0001.

Figure 3.